Results 31 to 40 of about 3,844,733 (310)

Disulfide-Modified Mesoporous Silica Nanoparticles for Biomedical Applications

open access: yesCrystals, 2023
Mesoporous silica nanoparticles (MSNs) are highly porous carriers used in drug and gene delivery research for biomedical applications due to their high surface area, narrow particle size distribution, and low toxicity.
Melissa Venedicto   +5 more
doaj   +1 more source

Cancer Research in 2021 [PDF]

open access: yesCancer Cell, 2021
Cancer research has been severely impacted by COVID-19. What does the future of cancer research look like in the new year after the pandemic?
openaire   +2 more sources

Cancer Research UK COVID Cancer Awareness Measures: Wave 1 and Wave 2, 2020-2021: Special Licence Access [PDF]

open access: yes, 2023
copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller ...
Cancer Research UK
core   +1 more source

Cancer Research UK Cancer Awareness Measures, 2019: Special Licence Access [PDF]

open access: yes, 2021
copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller ...
Cancer Research UK
core  

Cancer Research UK Cancer Awareness Measures, 2017 [PDF]

open access: yes, 2020
copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A.,
Cancer Research UK
core  

The state of cancer research in fragile and conflict-affected settings in the Middle East and North Africa Region: A bibliometric analysis

open access: yesFrontiers in Oncology, 2023
BackgroundCancer represents a disproportionate burden in LMICs, especially conflict-affected countries in the MENA region. Research output on cancer fails to match the growing burden in the region.
Zahi Abdul Sater   +8 more
doaj   +1 more source

The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification. [PDF]

open access: yes, 2021
Therapeutic cancer vaccines, an exciting development in cancer immunotherapy, share the goal of creating and amplifying tumor-specific T-cell responses, but significant obstacles still remain to their success.
Harrington, KJ   +4 more
core   +1 more source

Cancer Research UK Cancer Awareness Measures, February 2023: Special Licence Access [PDF]

open access: yes, 2023
copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller ...
Cancer Research UK
core  

Standard operating procedures for biobank in oncology

open access: yesFrontiers in Molecular Biosciences, 2022
Biobanks are biorepositories that collect, process, store, catalog, and distribute human biological samples, and record the associated data. The role and action field of these strategic infrastructures for implementing precision medicine in translational
Giuseppina Bonizzi   +18 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy